Gainesville, Florida 32610


Purpose:

This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreata-biliary disorders.


Study summary:

Cholangioscopy allows for direct visualization of the bile and pancreatic duct. In 2006, the SpyGlass Direct Visualization System for per-oral cholangiopancreatoscopy was introduced and since then has been shown to provide incremental diagnostic and therapeutic benefits. The main limitations of the original SpyGlass platform are fiberoptic visualization system, limited tip angulation, square cut Spy scope tip, and complex multicomponent setup. A new generation cholangioscopy platform, SpyGlass DS is currently in clinical use. The new system addresses many of the shortcomings of old platform including digital optics, improved tip angulation, tapered tip and simplified set up. It is unclear at this time wether this technical improvement will translate into better outcomes. Therefore, the investigators want to study the clinical utility of SpyGlass DS by prospectively collecting data on the clinical outcomes of patients undergoing cholangioscopy with Spyglass DS as part of their routine medical care.


Criteria:

Inclusion Criteria: - Participants who have been scheduled to undergo a cholangiopancreatoscopy as routine clinical care Exclusion Criteria: - failure to provide informed consent - any contraindications to endoscopy


NCT ID:

NCT02524418


Primary Contact:

Principal Investigator
Peter V Draganov, MD
University of Florida

Peter V Draganov, MD
Phone: 352-273-9474
Email: dragapv@medicine.ufl.edu


Backup Contact:

N/A


Location Contact:

Gainesville, Florida 32610
United States

Peter V Draganov, MD
Phone: 352-273-9400
Email: peter.draganov@medicine.ufl.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.